FUND II

Generating profitable returns for investors through medical device innovation
BioStar II
$36M

 

With a final closing in June 2010, BioStar II has invested in medical device companies specifically focused in the growing markets of cardiovascular and orthopaedics. BioStar II manages committed capital of $36M and is no longer making new investments.

 

Active

 

 

Exits